Project Grant HT94252510883
Award Date 9/15/25
Completion Date 9/14/29
Dollars Obligated $2.6M
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Durham, NC 27705, USA
Similar Awards
- This federal Project Grant award of $1,626,500.00 was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to The Regents of the University of California, San Francisco (UCSF). The grant supports advanced biomedical research aimed at transforming healthcare for military service members, veterans, and the broader public. The research initiative, titled the "MCCAIN/BAYH GLIOBLASTOMA CONSORTIUM," will focus on developing...
- This $1,626,438 Project Grant award from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports biomedical research conducted by the University of Texas MD Anderson Cancer Center (MD Anderson) to transform healthcare for military service members, veterans, and the general public. The research project, known as the "MCCAIN/BAYH GLIOBLASTOMA CONSORTIUM", will investigate innovative medical solutions for glioblastoma, an aggressive form of...
- This $161,000 federal Project Grant award, funded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), supports research at Duke University to investigate "Breast Cancer Brain Metastases: Integrating Immunogenomic and Phenotypic Vulnerabilities to Improve Outcomes." The research aims to develop innovative approaches to understand complex biological systems, create new diagnostic tools, and explore potential therapeutic interventions...
- This Project Grant award of $240,897.00 from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports research at Duke University to conduct integrative transcriptomic and epigenomic profiling of subependymal giant cell astrocytoma at single-cell resolution. The award, with a performance period from August 1, 2025 to July 31, 2027, will enable Duke University's Office of Research Administration to carry out this advanced biomedical research focused...
- The Defense Health Agency awarded Duke University a $1,167,250 Project Grant (CFDA 12.420 - Military Medical Research and Development) with a performance period from June 1, 2024 to May 31, 2027. The grant funding supports Duke's research on the role of the NLRP3-NLRC5 signaling pathway in melanoma immune evasion and dormancy. The research aims to advance the understanding of mechanisms underlying melanoma progression, with the potential to inform new therapeutic approaches. As a prominent...
- The Department of Defense's Defense Health Agency awarded a $4,818,759 Project Grant to Duke University under the Military Medical Research and Development program (CFDA 12.420) for the project "SINGLE-CELL AND SPATIAL ANALYSIS OF LETHAL BREAST CANCERS". The grant, awarded on April 1, 2024, will fund research to improve understanding and treatment of lethal breast cancers through advanced single-cell and spatial analysis techniques. This work supports the program's goals of...
- The Defense Health Agency awarded Duke University a $759,627.49 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to conduct research on "ACCELERATED AGING IN GULF WAR ILLNESS: PHENOTYPES, EPIGENETIC BIOMARKERS, AND ASSOCIATIONS WITH GULF WAR EXPOSURES." The project will run from August 1, 2023 to July 31, 2026. Duke University, a top-ranked global research institution, will be the prime awardee and perform the research through its Office of...
- The U.S. Defense Health Agency awarded a $241,500 Project Grant to Duke University under the Military Medical Research and Development program (CFDA 12.420) to conduct research on "UNDERSTANDING THE MOLECULAR COMMUNICATION BETWEEN PROSTATE CANCER CELL TYPES." The two-year grant, with a performance period from September 1, 2025 to August 31, 2027, will support advanced biomedical research aimed at transforming healthcare for military service members, veterans, and the broader public....
- The Department of the Army Medical Command awarded a $1,000,000 project grant to Duke University's Office of Research Administration Division under the Military Medical Research and Development program (CFDA 12.420). The grant, awarded on June 1, 2024 and running through May 31, 2027, will fund a practical multi-domain risk model of Alzheimer's disease and related dementias for veteran and non-veteran older U.S. adults. The research project aims to improve the health and care of military service...
- The Defense Health Agency awarded Duke University a $3,811,150.00 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to conduct a research project titled "SINGLE-CELL AND SPATIAL ANALYSIS OF LETHAL BREAST CANCERS". The grant period runs from April 1, 2024 to March 31, 2028. The key products and services to be delivered under this award include comprehensive single-cell and spatial analysis of breast cancer samples to characterize tumor heterogeneity...